Natera, Inc. (NASDAQ:NTRA – Get Free Report) CFO Michael Burkes Brophy sold 3,235 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $65.09, for a total value of $210,566.15. Following the completion of the transaction, the chief financial officer now directly […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report) CFO Michael Burkes Brophy sold 2,202 shares of Natera stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $65.86, for a total value of $145,023.72. Following the sale, the chief financial officer now owns 65,754 shares in the […]
Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) have been given an average rating of “Buy” by the twelve brokerages that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation […]
Rhenman & Partners Asset Management AB trimmed its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 7.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 200,000 shares of the medical research company’s stock after selling 17,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Natera were worth $9,732,000 […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report) CFO Michael Burkes Brophy sold 1,372 shares of the company’s stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $45.98, for a total value of $63,084.56. Following the completion of the sale, the chief financial officer now owns […]